CERSCerus Corporation

$335M

Q4 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$17M+1.8% YoY

Gross Profit

$8M48.9% margin

Operating Income

-$15M-93.5% margin

Net Income

-$16M-98.1% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+7.3%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$163M

Total Liabilities

$79M

Stockholders' Equity

$85M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$16M	+1.8%
Gross Profit	$8M	$7M	+13.7%
Operating Income	-$15M	-$11M	-42.5%
Net Income	-$16M	-$11M	-41.1%

Revenue Segments

Product

$17M82%

Government Contract

$4M18%

CERS Q4 2018 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena